This inventor holds 1 USPTO granted patent. Top assignee: Augusta Spinco Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Vincent Blanchette and Diagnostic Testing Innovation
Introduction
Vincent Blanchette is an inventor associated with Quebec, Canada, and Augusta Spinco Corporation. His patent work addresses diagnostic testing for vaginal disorders, including vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis.
Latest Patents
Blanchette is associated with 1 patent, titled “Buffer Compositions for Reducing Aggregation.” The patent describes compositions, kits, and methods for nucleic acid-based detection and identification of vaginal disorders. These approaches are designed to support robust diagnostic performance in the presence of interfering substances, such as gels found in clinical vaginal-swab samples.
Career Highlights
Blanchette’s listed invention focuses on improving the reliability of molecular diagnostic testing for vaginal disorders. His work is associated with Augusta Spinco Corporation.
Collaborations
Blanchette’s listed coworkers include Sebastien Morasse and Sophie Guay.
Conclusion
Vincent Blanchette’s patent work centers on buffer compositions intended to help make nucleic acid-based testing for vaginal disorders more robust against sample interference.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile